Experiment 520192
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Organism | Empty organism |
| Citation | UCKUN,FM: EVANS,WE: FORSYTH,CJ: WADDICK,KG: AHLGREN,LT: CHELSTROM,LM: BURKHARDT,A: BOLEN,J: MYERS,DE:. (1995). BIOTHERAPY OF B-CELL PRECURSOR LEUKEMIA BY TARGETING GENISTEIN TO CD19-ASSOCIATED TYROSINE KINASES.. 267() |
| Amount utilized | |
| Compound isolated | |
| Disease | B43-GENISTEIN IMMUNOCONJUGATE HAS SUBSTANTIALLY LONGER ELIMINATION HALF-LIFE AND SLOWER PLASMA CLEARANCE THAN UNCONJUGATED GENISTEIN. |
| Dose amount | 58.0 PICOMOLS |
| Number | 7 |
| Qualitative result | ACTIVE |
| Per unit | ANIMAL |
| Dose expression | DOSE |